Form 4 MiniMed Group, Inc. For: Mar 25 Filed by: Dallara Que
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
William Blair Starts MiniMed Group (MMED) at Outperform
March 31, 2026 6:16 AM EDTWilliam Blair analyst Steven Lichtman initiates coverage on MiniMed Group (NASDAQ: MMED) with a Outperform rating.
The analyst comments "MiniMed is a pure-play diabetes devices company with a broad product portfolio spanning insulin pumps, continuous glucose monitors (CGMs), insulin pens, and software algorithms that create smart, connected devices. Over the past few years, MiniMed has improved its new... More
Evercore ISI Starts MiniMed Group (MMED) at Outperform
March 31, 2026 6:01 AM EDTEvercore ISI analyst Daniel Markowitz initiates coverage on MiniMed Group (NASDAQ: MMED) with a Outperform rating and a price target of $20.00.
The analyst comments "We see an attractive buying opportunity in a turnaround story that has already begun to take hold under... More
Mizuho Starts MiniMed Group (MMED) at Outperform
March 31, 2026 5:07 AM EDTMizuho analyst Anthony Petrone initiates coverage on MiniMed Group (NASDAQ: MMED) with a Outperform rating and a price target of $21.00.
The analyst comments "Our OP rating on MMED is predicated on: 1) attractiveness of underlying Diabetes space valued at $18bn globally growing high-teens... More
